COVID-19在儿童1型糖尿病酮症酸中毒期间加剧胰岛素抵抗
该回顾性研究比较了儿童1型糖尿病合并或不合并COVID-19时,标准化酮症酸中毒治疗期间的组织葡萄糖处置率。共纳入93例COVID-19阴性患者和15例阳性患者,两组基线特征相似。COVID-19阳性患者的中位组织葡萄糖处置率较阴性患者低46%(P=0.013)。作者认为COVID-19在通常导致儿童酮症酸中毒的因素之上引发了代谢紊乱。
要点
- 儿童1型糖尿病酮症酸中毒合并COVID-19时,中位组织葡萄糖处置率较未合并者低46%。
- 两组基线特征相似,提示组织葡萄糖处置率差异可能与COVID-19相关。
- 作者强调COVID-19对儿童1型糖尿病构成直接威胁,应通过疫苗接种等加强预防和监测。
核心结论
- COVID-19在通常导致儿童酮症酸中毒的因素之上引发了代谢紊乱,这些发现强调COVID-19对儿童1型糖尿病的显著直接威胁,以及通过疫苗接种等作为一级预防进行缓解和监测的重要性。
研究设计与样本
- 回顾性比较所有既往1型糖尿病儿童在标准化酮症酸中毒治疗期间的组织葡萄糖处置率,按有无COVID-19分组。
- 病例评估从2020年6月19日首例COVID-19阳性酮症酸中毒至2022年2月2日。
- 共纳入93例COVID-19阴性患者和15例COVID-19阳性患者,两组基线特征相似。
主要发现
- COVID-19阳性患者的中位组织葡萄糖处置率较COVID-19阴性患者低46%(P=0.013)。
临床怎么用
- 作者认为这些发现强调COVID-19对儿童1型糖尿病的显著直接威胁,并强调通过疫苗接种等作为一级预防进行缓解和监测的重要性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Although mortality from coronavirus disease 2019 (COVID-19) among youth with type 1 diabetes is rare, severe acute respiratory syndrome coronavirus 2 is associated with increased pediatric hospitalizations for diabetic ketoacidosis (DKA). To clarify whether the relationship between COVID-19 and DKA is coincidental or causal, we compared tissue glucose disposal (TGD) during standardized treatment for DKA between pediatric patients with COVID-19 and those without COVID-19. RESEARCH DESIGN AND METHODS: We retrospectively compared TGD during standardized therapy for DKA in all children with preexisting type 1 diabetes with or without COVID-19. Cases were assessed beginning with the first case of COVID-19-positive DKA on 19 June 2020 through 2 February 2022. RESULTS: We identified 93 COVID-19-negative patients and 15 COVID-19-positive patients who were treated for DKA, with similar baseline characteristics between groups. Median TGD was 46% lower among patients who had COVID-19 compared with those who did not (P = 0.013). CONCLUSIONS: These results suggest that COVID-19 provokes a metabolic derangement over and above factors that typically contribute to pediatric DKA. These findings underscore the significant and direct threat posed by COVID-19 in pediatric type 1 diabetes and emphasize the importance of mitigation and monitoring including through vaccination as a primary prevention.
引用
- Keiner ES, Slaughter JC, Datye KA, et al. COVID-19 Exacerbates Insulin Resistance During Diabetic Ketoacidosis in Pediatric Patients With Type 1 Diabetes. Diabetes Care. 2022. PMID: 35944264. doi:10.2337/dc22-0396
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。